CD20-Targeted α-Radionuclides Synergize with Immune Checkpoint Inhibition to Treat Murine Lymphoma.
Saved in:
| Title: | CD20-Targeted α-Radionuclides Synergize with Immune Checkpoint Inhibition to Treat Murine Lymphoma. |
|---|---|
| Authors: | O'Steen S; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington; sosteen@fredhutch.org damiangreen@miami.edu., Lee SY; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington., Comstock ML; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington., Kehret AR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington., Lin Y; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington., Hamlin DK; Department of Radiation Oncology, University of Washington, Seattle, Washington., Dexter SL; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington., Hippe DS; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; and., Gooley TA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; and., Wilbur DS; Department of Radiation Oncology, University of Washington, Seattle, Washington., Li Y; Department of Radiation Oncology, University of Washington, Seattle, Washington., Walter RB; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; and.; School of Medicine, University of Washington, Seattle, Washington., Till B; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; and.; School of Medicine, University of Washington, Seattle, Washington., Orozco JJ; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington.; School of Medicine, University of Washington, Seattle, Washington., Green DJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; and sosteen@fredhutch.org damiangreen@miami.edu.; School of Medicine, University of Washington, Seattle, Washington. |
| Source: | Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2026 May 01; Vol. 67 (5), pp. 693-699. Date of Electronic Publication: 2026 May 01. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1535-5667 |
|---|---|
| DOI: | 10.2967/jnumed.125.270515 |
